Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 10, 2022 07:00 ET | Source: Frontier Medicines

Frontier Medicines Announces Advancement of First Program Under Global Partnership with AbbVie

SOUTH SAN FRANCISCO, Calif., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Frontier Medicines Corporation, a precision medicine company seeking to unlock the proteome to advance breakthroughs against otherwise...
January 05, 2022 08:00 ET | Source: Frontier Medicines

Frontier Medicines to Present at the 40th Annual J.P. Morgan Healthcare Conference

SOUTH SAN FRANCISCO, Calif., Jan. 05, 2022 (GLOBE NEWSWIRE) -- Frontier Medicines Corporation, a precision medicine company seeking to unlock the proteome to advance breakthroughs against otherwise...
December 09, 2021 08:00 ET | Source: Frontier Medicines

Frontier Medicines to Present at the RBC Capital Markets Healthcare Private Company Virtual Conference

SOUTH SAN FRANCISCO, Calif., Dec. 09, 2021 (GLOBE NEWSWIRE) -- Frontier Medicines Corporation, a precision medicine company seeking to unlock the proteome to advance breakthroughs against otherwise...
November 17, 2021 08:00 ET | Source: Frontier Medicines

Frontier Medicines Announces the Appointment of Marguerite Hutchinson, J.D., as Chief Business Officer

SOUTH SAN FRANCISCO, Calif., Nov. 17, 2021 (GLOBE NEWSWIRE) -- Frontier Medicines Corporation, a precision medicine company seeking to unlock the proteome to advance breakthroughs against otherwise...
November 10, 2021 16:00 ET | Source: Frontier Medicines

Frontier Medicines to Present at Two Upcoming Investor Conferences in November

SOUTH SAN FRANCISCO, Calif., Nov. 10, 2021 (GLOBE NEWSWIRE) -- Frontier Medicines Corporation, a precision medicine company seeking to unlock the proteome to advance breakthroughs against otherwise...
September 23, 2021 08:00 ET | Source: Frontier Medicines

Frontier Medicines to Present at the Cantor Global Healthcare Conference

SOUTH SAN FRANCISCO, Calif., Sept. 23, 2021 (GLOBE NEWSWIRE) -- Frontier Medicines Corporation, a precision medicine company seeking to unlock the proteome to advance breakthroughs against otherwise...
July 19, 2021 08:00 ET | Source: Frontier Medicines

Frontier Medicines Raises $88.5 Million Series B Financing to Advance Precision Oncology and Targeted Protein Degradation Pipeline

—Funding to Enhance Research and Development of Pipeline, Including Lead Program Targeting Activated KRASG12C— —Proceeds to Further Accelerate the Development of Foundational Technologies in...